MedikinaBio, a developer of in vitro diagnostic medical devices for liver cancer, enters into an international joint clinical trial agreement with Mongolia’s National Institute of Medical Research
On October 30, 2023, MediKina Bio (CEO Choi Woo-seong) signed a memorandum of understanding for international joint clinical trials with ...